Table 3.
Any chronic pain | Lower-impact CP | High-impact CP | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n* | N† | 95 CI | Pop. %‡ | 95 CI | N | Pop. % | 95 CI | N | Pop. % | 95 CI | |
No A/D symptoms§ | 5559 | 38.0 | 3.6, 4.0 | 17.1% | 16.6, 17.7 | 27.0 | 12.2% | 11.7, 12.7 | 11.0 | 5.0% | 4.7, 5.2 |
A/D symptoms | 1599 | 12.0 | 11.1, 12.8 | 55.6% | 53.2, 57.9 | 4.8 | 22.2% | 20.3, 24.1 | 7.2 | 33.4% | 31.1, 35.6 |
Depression only | 503 | 3.7 | 3.3, 4.1 | 55.9% | 51.8, 60.1 | 1.6 | 24.0% | 10.6, 27.6 | 2.1 | 31.9% | 28.0, 35.7 |
Anxiety only | 255 | 1.9 | 1.6, 2.2 | 41.5% | 36.4, 46.6 | 1.1 | 23.9% | 19.3, 28.5 | 0.8 | 17.6% | 13.9, 21.3 |
Depression and anxiety | 829 | 6.3 | 5.8, 6.8 | 61.3% | 58.1, 64.5 | 2.1 | 20.2% | 17.6, 22.8 | 4.2 | 41.1% | 37.9, 44.4 |
Data Source: National Center for Health Statistics, National Health Interview Survey, 2019.
n = number of responses in survey sample.
N = national prevalence, reported in millions of US adults.
Pop. % = national prevalence as a proportion of the US adult general population.
A/D symptoms are defined as clinically significant symptoms of anxiety, depression, or both.
A/D, anxiety/depression; CP, chronic pain.